A chemical method for generating live-attenuated, replication-defective DNA viruses for vaccine development.

Jaijyan, Dabbu Kumar; Govindasamy, Kavitha; Lee, Moses; Zhu, Hua

Jaijyan, Dabbu Kumar; Govindasamy, Kavitha; Lee, Moses; Zhu, Hua.

Afiliación

Jaijyan DK; Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers - New Jersey Medical School, 225 Warren Street, Newark, NJ 07103, USA.
Govindasamy K; New Jersey Center for Science, Technology and Mathematics, Kean University, Union, NJ, USA.
Lee M; Department of Chemistry, Georgia State University, Atlanta, GA, USA.
Zhu H; Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers - New Jersey Medical School, 225 Warren Street, Newark, NJ 07103, USA.

Cell Rep Methods ; 2(9): 100287, 2022 09 19.

Article en En | MEDLINE | ID: mdl-36160049

Asunto(s)

Herpesvirus Humano 2; Inmunización; Animales; Ratones; Humanos; Herpesvirus Humano 2/genética; Vacunación; ADN; Desarrollo de Vacunas

Palabras clave

CM; DNA viruses; centanamycin; cytomegalovirus; herpes simplex virus; inactivated viruses; live-attenuated viruses; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunización / Herpesvirus Humano 2 Límite: Animals / Humans Idioma: En Revista: Cell Rep Methods Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google